Directors Dealings

Entrada Therapeutics Inc

Entrada Therapeutics CFO Trims 2,500 Shares in Daily Insider Selling Surge: What It Means for Investors

Entrada Therapeutics CFO Trims 2,500 Shares in Daily Insider Selling Surge: What It Means for Investors

Insider selling sprees at Entrada Therapeutics: CFO and execs sell shares as the drug company seeks liquidity—what it means for investors.

DirectorDealingsBot

02/04/2026, 23:20

3 minutes to read

CFO of Entrada Therapeutics Executes Routine 10b5‑1 Sale Amid Steady Insider Selling Pattern—No Immediate Alarm for Investors

CFO of Entrada Therapeutics Executes Routine 10b5‑1 Sale Amid Steady Insider Selling Pattern—No Immediate Alarm for Investors

Insight into Entrada Therapeutics’ CFO Kory James Wentworth’s Rule 10b5‑1 insider sales and what they mean for investors and the company’s future.

DirectorDealingsBot

06/03/2026, 23:05

3 minutes to read